Vaccination against COVID-19 is one of the critical tools to provide herd immunity, reduce
mortality, and control the pandemic worldwide. Despite the safety of vaccination against …

OBJECTIVE: An increasing number of new on-set autoimmune-inflammatory rheumatic
diseases (AIRD) after COVID-19 vaccination has begun to be reported in the literature. In …

Autoimmunity linked to COVID-19 immunization has been recorded throughout the
pandemic. Herein we present six new patients who experienced relapses of previous …

Clinical data on vaccinated patients with coronavirus disease 2019 (COVID-19) who have
systemic autoimmune and autoinflammatory rheumatic diseases (SAARD) are limited. This …

Autoimmune and autoinflammatory rheumatic disorders (ARD) are treated with
antimetabolites, calcineurin inhibitors and biologic agents either neutralizing cytokines …

Objectives Successful vaccination is key to overcoming the COVID-19 pandemic.
Immunosuppressive medication is known to potentially compromise vaccination responses …

Background Patients with autoimmune rheumatic diseases (ARD) are at a potentially higher
risk for COVID-19 infection complications. Given their inherent altered immune system and …

Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-
2 infection. Vaccination against this infection can prevent the patients from developing …

Introduction Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) became a
major concern since the announcement that it is a pandemic in early 2020. Vaccine trials …

Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …